Frontiers in Cell and Developmental Biology

Original Research

Published on 24 Jan 2024

Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma

in Cancer Cell Biology

Su Ir Lyu
Jannik Johannsen
Adrian Georg Simon
Karl Knipper
Nora Wuerdemann
Shachi Jenny Sharma
Martin Thelen
Kevin Karl Hansen
Caroline Fretter
Charlotte Klasen

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1337361

2,268 views
3 citations

Original Research

Published on 23 Jan 2024

p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation

in Cancer Cell Biology

Ludovica Lopresti
Nagaja Capitani
Vanessa Tatangelo
Carmela Tangredi
Gioia Boncompagni
Federica Frezzato
Andrea Visentin
Giuseppe Marotta
Sara Ciofini
Alessandro Gozzetti

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1297116

1,899 views
2 citations

Original Research

Published on 16 Jan 2024

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

in Cancer Cell Biology

Yoshiro Nakahara
Taku Kouro
Satoru Motoyama
Masatomo Miura
Kazuma Fujita
Yuka Igarashi
Naoko Higashijima
Norikazu Matsuo
Hidetomo Himuro
Feifei Wei

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1324898

2,296 views

Review

Published on 10 Jan 2024

Metastasis and cancer associated fibroblasts: taking it up a NOTCH

in Cancer Cell Biology

Argha Ghosh
Anirban K. Mitra

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1277076

4,595 views

Review

Published on 09 Jan 2024

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target

in Cancer Cell Biology

Minpu Zhang
Cun Liu
Ye Li
Huayao Li
Wenfeng Zhang
Jingyang Liu
Liquan Wang
Changgang Sun

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1332205

5,684 views
7 citations

Methods

Published on 08 Jan 2024

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer

in Cancer Cell Biology

Hongxiao Zhang
Shuxian Niu
Huanhuan Chen
Lihua Wang
Xiaoyu Wang
Yujiao Wu
Jiaxin Shi
Zhuoning Li
Yanjun Hu
Zhiguang Yang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1220320

1,945 views
2 citations

Review

Published on 03 Jan 2024

Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming

in Cancer Cell Biology

Dyana Sari
Devrim Gozuacik
Yunus Akkoc

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1274682

4,237 views
3 citations

Original Research

Published on 22 Dec 2023

Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation

in Cancer Cell Biology

Ruben Valente
Sandra Cordeiro
André Luz
Maria C. Melo
Catarina Roma Rodrigues
Pedro V. Baptista
Alexandra R. Fernandes

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1310397

4,366 views
9 citations

Review

Published on 21 Dec 2023

Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle

in Cancer Cell Biology

Cintia Daniela Kaufman
Cecilia Farré
Lucía Biscari
Ana Rosa Pérez
Andrés Alloatti

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1260423

4,377 views
1 citation

Original Research

Published on 19 Dec 2023

Development of a monoclonal antibody to ITPRIPL1 for immunohistochemical diagnosis of non-small cell lung cancers: accuracy and correlation with CD8+ T cell infiltration

in Cancer Cell Biology

Shouyan Deng
Jiawei Shi
Yufan Sun
Yingfei Quan
Zan Shen
Yonggang Wang
Hai Li
Jie Xu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1297211

4,117 views
1 citation

Review

Published on 15 Dec 2023

Applications of CRISPR screening to lung cancer treatment

in Cancer Cell Biology

Wanying Shen
Fangli Hu
Pan Lei
Yijun Tang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1295555

4,480 views
1 citation

Original Research

Published on 13 Dec 2023

Identification of efferocytosis-related subtypes in gliomas and elucidating their characteristics and clinical significance

in Cancer Cell Biology

Mengge Gao
Jinsheng Huang
Bo Yang
Qiong Liu
Miaoqing Luo
Biying Yang
Xujia Li
Xiaofang Liu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1295891

3,367 views
1 citation

Review

Published on 11 Dec 2023

Applications and advancements of CRISPR-Cas in the treatment of lung cancer

in Cancer Cell Biology

Pan Lei
Yixin Ju
Fenfen Peng
Jie Luo

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1295084

4,604 views
2 citations

Original Research

Published on 07 Dec 2023

Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy

in Cancer Cell Biology

Tanya E. Kelly
Cathy L. Spillane
Mark P. Ward
Karsten Hokamp
Yanmei Huang
Prerna Tewari
Cara M. Martin
Lucy A. Norris
Bashir M. Mohamed
Mark Bates

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1150991

2,805 views
5 citations

Mini Review

Published on 30 Nov 2023

Crosstalk of nervous and immune systems in pancreatic cancer

in Cancer Cell Biology

Fei-Fei Huang
Wen-Hui Cui
Lan-Yue Ma
Qi Chen
Yang Liu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1309738

3,973 views
1 citation

Original Research

Published on 30 Nov 2023

Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer

in Cancer Cell Biology

Linjie Zhang
Yizhang Deng
Jingbang Yang
Wuguo Deng
Liren Li

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1202193

3,781 views
3 citations

Navigation group

Articles

Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma

p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

Metastasis and cancer associated fibroblasts: taking it up a NOTCH

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer

Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming

Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation

Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle

Development of a monoclonal antibody to ITPRIPL1 for immunohistochemical diagnosis of non-small cell lung cancers: accuracy and correlation with CD8+ T cell infiltration

Applications of CRISPR screening to lung cancer treatment

Identification of efferocytosis-related subtypes in gliomas and elucidating their characteristics and clinical significance

Applications and advancements of CRISPR-Cas in the treatment of lung cancer

Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy

Crosstalk of nervous and immune systems in pancreatic cancer

Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer